Atuka provides contract research and consultancy services for the biopharmaceutical industry to aid the development of novel therapeutics and diagnostics for Parkinson's disease.

In addition to conducting fee-for-service pre-clinical and clinical research, we continually assess and appraise evolving drug development activity for Parkinson's disease and related disorders.

Atuka was founded in 2003 by Dr. Jonathan Brotchie, an expert in the field of Parkinson’s disease, and has grown rapidly. We have a corporate presence in the UK, Canada and China.